The epidemiology of multidrug-resistant organisms in persons diagnosed with cancer in Norway, 2008–2018: expanding surveillance using existing laboratory and register data

Journal article

During the COVID-19 pandemic, the Norwegian Ministry of Health asked the Norwegian Institute of Public Health (NIPH) to establish a research centre to support decision making in epidemics. The request was directly related to the weak evidence base for the effects of infection control interventions during the COVID-19 pandemic. The Centre for Epidemic Interventions Research (CEIR) was formally established in the autumn of 2021, hosted by the Norwegian Institute of Public Health (NIPH). CEIR has been tasked with three main activities, as defined by the following aims: 1. Prepare for the conduct of studies of effects of non-pharmaceutical infection control measures. 2. Carry out effect studies of infection control measures. 3. Develop and evaluate tools to support the use of research in decision-making in health crises and improve critical health literacy in the population.publishedVersio

Authors: Danielsen, AS; Elstrøm, P; Eriksen-Volle, H-M; Hofvind, S; Eyre, DW

• Publication status: Published
• Peer review status: Peer reviewed
• Publisher: Springer
• Journal: European Journal of Clinical Microbiology and Infectious Diseases
• Volume: 43
• Issue: 1
• Pages: 121-132
• Publication date: 2023-11-18
• DOI: 10.1007/s10096-023-04698-3
• EISSN: 1435-4373
• ISSN: 0934-9723
• Language: English
• Keywords: Medical microbiology; Drug resistance; Epidemiology; Cancer; Microbiology; Cohort; Infection control; Immunology; Biology; Internal medicine; Intensive care medicine; Cohort study; Linezolid; Vancomycin; Medicine; Staphylococcus aureus; Incidence (geometry); Multiple drug resistance